The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
Gene-expression profiles predict survival of patients with lung adenocarcinoma
Beer, D. G., Kardia, S. L. R., Huang, C.-C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., et al. (2002) · Nature Medicine · doi:10.1038/nm733 · Cited by 2,025 · cited 1×
“This method is a robust and acceptable alternative statistical approach when separate training and testing sets are not available (Stone, 1977; Beer et al., 2002).”
MethodSelf-citationHundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1 · Cited by 1,836
Gene-Expression Profiles in Hereditary Breast Cancer
Hedenfalk, I., Duggan, D., Chen, Y., Radmacher, M., Bittner, M., Simon, R., Meltzer, P., Gusterson, B., Esteller, M., Raffeld, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102223440801 · Cited by 1,733
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
DEGROOT, L. J., KAPLAN, E. L., MCCORMICK, M., & STRAUS, F. H. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-414 · Cited by 1,049
Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030838 · Cited by 1,042
Self-citationBRAF Mutation in Papillary Thyroid Carcinoma
Cohen, Y., Xing, M., Mambo, E., Guo, Z., Wu, G., Trink, B., Beller, U., Westra, W. H., Ladenson, P. W., & Sidransky, D. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.8.625 · Cited by 922
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
Soares, P., Trovisco, V., Rocha, A. S., Lima, J., Castro, P., Preto, A., Máximo, V., Botelho, T., Seruca, R., & Sobrinho-Simões, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206706 · Cited by 679
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Observer Variation in the Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma
Lloyd, R. V., Erickson, L. A., Casey, M. B., Lam, K. Y., Lohse, C. M., Asa, S. L., Chan, J. K. C., DeLellis, R. A., Harach, H. R., Kakudo, K., et al. (2004) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000135519.34847.f6 · Cited by 498
RET/PTC Rearrangement in Thyroid Tumors
Nikiforov, Y. E. (2002) · Endocrine Pathology · doi:10.1385/ep:13:1:03 · Cited by 489
Self-citationOncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer
Ciampi, R., Knauf, J. A., Kerler, R., Gandhi, M., Zhu, Z., Nikiforova, M. N., Rabes, H. M., Fagin, J. A., & Nikiforov, Y. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523237 · Cited by 461
Self-citationGene expression in papillary thyroid carcinoma reveals highly consistent profiles
Huang, Y., Prasad, M., Lemon, W. J., Hampel, H., Wright, F. A., Kornacker, K., LiVolsi, V., Frankel, W., Kloos, R. T., Eng, C., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251547398 · Cited by 442
B-RAF is a therapeutic target in melanoma
Karasarides, M., Chiloeches, A., Hayward, R., Niculescu-Duvaz, D., Scanlon, I., Friedlos, F., Ogilvie, L., Hedley, D., Martin, J., Marshall, C. J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207785 · Cited by 426
Discovery of a novel Raf kinase inhibitor.
Lyons, J. F., Wilhelm, S., Hibner, B., & Bollag, G. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080219 · Cited by 416
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T. (2005) · Nature Genetics · doi:10.1038/ng1490 · Cited by 414
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro, M., Carlomagno, F., Hay, I. D., Herrmann, M. A., Grieco, M., Melillo, R., Pierotti, M. A., Bongarzone, I., Della Porta, G., & Berger, N. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115743 · Cited by 390
Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis
Giordano, T. J., Thomas, D. G., Kuick, R., Lizyness, M., Misek, D. E., Smith, A. L., Sanders, D., Aljundi, R. T., Gauger, P. G., Thompson, N. W., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63846-1 · Cited by 383
Self-citationDonghi, R., Longoni, A., Pilotti, S., Michieli, P., Della Porta, G., & Pierotti, M. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116385 · Cited by 370
Point Mutations of Ras Oncogenes are an Early Event in Thyroid Tumorigenesis
Namba, H., Rubin, S. A., & Fagin, J. A. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-10-1474 · Cited by 356
Zhu, Z., Gandhi, M., Nikiforova, M. N., Fischer, A. H., & Nikiforov, Y. E. (2003) · American Journal of Clinical Pathology · doi:10.1309/nd8d9lajtrctg6qd · Cited by 355
Self-citationBounacer, A., Wicker, R., Caillou, B., Cailleux, A. F., Sarasin, A., Schlumberger, M., & Suárez, H. G. (1997) · Oncogene · doi:10.1038/sj.onc.1200206 · Cited by 339
Gene Expression Profiles of BRCA1-Linked, BRCA2-Linked, and Sporadic Ovarian Cancers
Jazaeri, A. A., Yee, C. J., Sotiriou, C., Brantley, K. R., Boyd, J., & Liu, E. T. (2002) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/94.13.990 · Cited by 282
Frattini, M., Ferrario, C., Bressan, P., Balestra, D., De Cecco, L., Mondellini, P., Bongarzone, I., Collini, P., Gariboldi, M., Pilotti, S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207980 · Cited by 266
Asymptotics for and against cross-validation
STONE, M. (1977) · Biometrika · doi:10.1093/biomet/64.1.29 · Cited by 264
Mutations of BRAF and KRAS Precede the Development of Ovarian Serous Borderline Tumors
Ho, C.-L., Kurman, R. J., Dehari, R., Wang, T.-L., & Shih, I.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2067 · Cited by 206
Giordano, T. J., Shedden, K. A., Schwartz, D. R., Kuick, R., Taylor, J. M. G., Lee, N., Misek, D. E., Greenson, J. K., Kardia, S. L. R., Beer, D. G., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62509-6 · Cited by 202
Self-citationMicroarray expression profiling in melanoma reveals a BRAF mutation signature
Pavey, S., Johansson, P., Packer, L., Taylor, J., Stark, M., Pollock, P. M., Walker, G. J., Boyle, G. M., Harper, U., Cozzi, S.-J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207563 · Cited by 183
Begum, S., Rosenbaum, E., Henrique, R., Cohen, Y., Sidransky, D., & Westra, W. H. (2004) · Modern Pathology · doi:10.1038/modpathol.3800198 · Cited by 175
Ras Oncogene Mutations in Benign and Malignant Thyroid Neoplasms
KARGA, H., LEE, J.-K., VICKERY, A. L., THOR, A., GAZ, R. D., & JAMESON, J. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-832 · Cited by 175
Opportunities and challenges in the development of kinase inhibitor therapy for cancer
Sawyers, C. L. (2003) · Genes & Development · doi:10.1101/gad.1152403 · Cited by 170
Identification and validation of an ERBB2 gene expression signature in breast cancers
Bertucci, F., Borie, N., Ginestier, C., Groulet, A., Charafe‐Jauffret, E., Adélaïde, J., Geneix, J., Bachelart, L., Finetti, P., Koki, A. T., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207361 · Cited by 164
Stepwise Participation of p53 Gene Mutation During Dedifferentiation of Human Thyroid Carcinomas
Dobashi, Y., Sugimura, H., Sakamoto, A., Mernyei, M., Mori, M., Oyama, T., & Machinami, R. (1994) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199403010-00003 · Cited by 164
Aldred, M. A., Huang, Y. S., Liyanarachchi, S., Pellegata, N. S., Gimm, O., Jhiang, S. M., Davuluri, R. V., de la Chapelle, A., & Eng, C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.127 · Cited by 150
Design and Discovery of Small Molecules Targeting Raf-1 Kinase
Lowinger, T. B., Riedl, B., Dumas, J., & Smith, R. A. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023393125 · Cited by 150
Wreesmann, V. B., Sieczka, E. M., Socci, N. D., Hezel, M. P., Belbin, T. J., Childs, G. J., Patel, S. G., Patel, K. N., Tallini, G., Prystowsky, M. B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1460 · Cited by 143
Molecular Profiling Distinguishes Papillary Carcinoma from Benign Thyroid Nodules
Finley, D. J., Arora, N., Zhu, B., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031811 · Cited by 141
Integrated global profiling of cancer
Hanash, S. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1414 · Cited by 137
Self-citationCuccuru, G., Lanzi, C., Cassinelli, G., Pratesi, G., Tortoreto, M., Petrangolini, G., Seregni, E. C., Martinetti, A., Laccabue, D., Zanchi, C., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh184 · Cited by 115
Carlomagno, F., Vitagliano, D., Guida, T., Basolo, F., Castellone, M. D., Melillo, R. M., Fusco, A., & Santoro, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021278 · Cited by 113
Silencing of the PTEN tumor‐suppressor gene in anaplastic thyroid cancer
Frisk, T., Foukakis, T., Dwight, T., Lundberg, J., Höög, A., Wallin, G., Eng, C., Zedenius, J., & Larsson, C. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10098 · Cited by 107
Tall Cell Variant: An Aggressive Form of Papillary Thyroid Carcinoma
Prendiville, S., Burman, K. D., Ringel, M. D., Shmookler, B. M., Deeb, Z. E., Wolfe, K., Azumi, N., Wartofsky, L., & Sessions, R. B. (2000) · Otolaryngology · doi:10.1016/s0194-5998(00)70047-7 · Cited by 106
Prevalence of Activating ras Mutations in Morphologically Characterized Thyroid Nodules
Ezzat, S., Zheng, L., KOLENDA, J., SAFARIAN, A., Freeman, J. L., & Asa, S. L. (1996) · Thyroid · doi:10.1089/thy.1996.6.409 · Cited by 98
Molecular pathogenesis of thyroid cancer
Segev, D. L., Umbricht, C. B., & Zeiger, M. A. (2003) · Surgical Oncology · doi:10.1016/s0960-7404(03)00037-9 · Cited by 88
Schaefer, K., Brachwitz, K., Wai, D., Braun, Y., Diallo, R. I., Korsching, E., Eisenacher, M., Voß, R., van Valen, F., Baer, C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0809 · Cited by 74
Predictive factors for epidermal growth factor receptor inhibitors—The bull's-eye hits the arrow
Dancey, J. E. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00122-9 · Cited by 73
Hawthorn, L., Stein, L. C., Varma, R., Wiseman, S., Loree, T. R., & Tan, D. (2004) · Head & Neck · doi:10.1002/hed.20099 · Cited by 66
Ras Oncogene Mutations in Thyroid Tumors
Capellá, G., Matías‐Guiu, X., Ampudia, X., de Leiva, A., Perucho, M., & Prat, J. (1996) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199603000-00008 · Cited by 66
Fagin, J. A. (2002) · Endocrinology · doi:10.1210/endo.143.6.8832 · Cited by 65
Miyagi, E., Braga‐Basaria, M., Hardy, E., Vasko, V. V., Burman, K. D., Jhiang, S. M., Saji, M., & Ringel, M. D. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20042 · Cited by 57
Looking Beyond Morphology: Cancer Gene Expression Profiling Using DNA Microarrays
Luo, J., Isaacs, W. B., Trent, J. M., & Duggan, D. J. (2003) · Cancer Investigation · doi:10.1081/cnv-120025096 · Cited by 50
Molecular pathogenesis of thyroid nodules and cancer
Moretti, F., Nanni, S., & Pontecorvi, A. (2000) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0101 · Cited by 50
S-100 Protein+ Dendritic Cells and CD34+ Dendritic Interstitial Cells in Thyroid Lesions
Batistatou, A. K., Zolota, V., & Scopa, C. D. (2002) · Endocrine Pathology · doi:10.1385/ep:13:2:111 · Cited by 29
Hironaka, K., Makino, H., Onbe, T., Yamasaki, Y., Shikata, K., Kamata, K., & Ota, Z. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199605)179:1<89::aid-path546>3.0.co;2-r · Cited by 9
Cited by
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Agrawal, N., Akbani, R., Aksoy, B. A., Ally, A., Arachchi, H., Asa, S. L., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.050 · Cited by 3,062
Self-citationMolecular pathogenesis and mechanisms of thyroid cancer
Xing, M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3431 · Cited by 1,426
Guidelines for the management of thyroid cancer
Perros, P., Boelaert, K., Colley, S., Evans, C., Evans, R. M., Gerrard BA, G., Gilbert, J., Harrison, B., Johnson, S. J., Giles, T. E., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12515 · Cited by 1,372
p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,123
Self-citationMolecular genetics and diagnosis of thyroid cancer
Nikiforov, Y. E., & Nikiforova, M. N. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.142 · Cited by 1,011
Self-citation
Metadata
- Authors
- Giordano, T. J., Kuick, R., Thomas, D. G., Misek, D. E., Vinco, M., Sanders, D., Zhu, Z., Ciampi, R., Roh, M., Shedden, K., Gauger, P., Doherty, G., Thompson, N. W., Hanash, S., Koenig, R. J., & Nikiforov, Y. E.
- Venue
- Oncogene
- Published
- 2005-06-27
- Volume
- 24
- Issue
- 44
- Pages
- 6646-6656
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2132601303
- Cited by
- 383
- References
- 58
- FWCI
- 15.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.